A business in context
PTCT research notebook
Read the disclosures. Follow the relationships. Keep the dates in view.
Filing timeline
Download filings CSVReported insider transactions
Download transactions CSVP · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift
| Transaction / filed | Reporting owner | Type | Security | Shares | Reported price |
|---|---|---|---|---|---|
| 2026-09-17 | SCHMERTZLER MICHAEL | S · Sale | Common Stock | 376.0 | 68.45 |
| 2026-09-17 | SCHMERTZLER MICHAEL | S · Sale | Common Stock | 9624.0 | 67.83 |
| 2026-09-16 | SCHMERTZLER MICHAEL | S · Sale | Common Stock | 2994.0 | 66.58 |
| 2026-09-16 | SCHMERTZLER MICHAEL | S · Sale | Common Stock | 7006.0 | 67.35 |
| 2026-09-10 | SCHMERTZLER MICHAEL | S · Sale | Common Stock | 10000.0 | 67.34 |
| 2026-09-09 | SCHMERTZLER MICHAEL | S · Sale | Common Stock | 9428.0 | 67.79 |
| 2026-09-09 | SCHMERTZLER MICHAEL | S · Sale | Common Stock | 572.0 | 68.67 |
| 2026-08-27 | SCHMERTZLER MICHAEL | S · Sale | Common Stock | 610.0 | 72.22 |
| 2026-08-27 | SCHMERTZLER MICHAEL | S · Sale | Common Stock | 11890.0 | 71.55 |
| 2026-08-26 | SCHMERTZLER MICHAEL | S · Sale | Common Stock | 6874.0 | 72.74 |
| 2026-08-26 | SCHMERTZLER MICHAEL | S · Sale | Common Stock | 5626.0 | 73.18 |
| 2026-08-20 | SCHMERTZLER MICHAEL | S · Sale | Common Stock | 691.0 | 72.92 |
| 2026-08-20 | SCHMERTZLER MICHAEL | S · Sale | Common Stock | 2390.0 | 71.88 |
| 2026-08-20 | SCHMERTZLER MICHAEL | S · Sale | Common Stock | 9419.0 | 70.78 |
| 2026-08-19 | SCHMERTZLER MICHAEL | S · Sale | Common Stock | 5335.0 | 72.86 |
| 2026-08-19 | SCHMERTZLER MICHAEL | S · Sale | Common Stock | 7165.0 | 73.67 |
| 2026-08-17 | Boulding Mark Elliott | M · Exercise / conversion | Common Stock | 2813.0 | 25.69 |
| 2026-08-17 | Boulding Mark Elliott | S · Sale | Common Stock | 969.0 | 72.9 |
| 2026-08-17 | Boulding Mark Elliott | S · Sale | Common Stock | 1844.0 | 72.39 |
| 2026-08-17 | Boulding Mark Elliott | M · Exercise / conversion | Stock Option (Right to Buy) | 2813.0 | 0.0 |
| 2026-08-04 | Klein Matthew B. | S · Sale | Common Stock | 10292.0 | 68.57 |
| 2026-07-28 | Sollie-Zetlmayer Hege Elisabeth | A · Grant / award | Common Stock | 2000.0 | 0.0 |
| 2026-07-28 | Sollie-Zetlmayer Hege Elisabeth | A · Grant / award | Common Stock | 4000.0 | 0.0 |
| 2026-07-28 | Sollie-Zetlmayer Hege Elisabeth | A · Grant / award | Stock Option (Right to Buy) | 3475.0 | 0.0 |
| 2026-07-28 | Sollie-Zetlmayer Hege Elisabeth | A · Grant / award | Stock Option (Right to Buy) | 1738.0 | 0.0 |
| 2026-07-14 | Gravier Pierre | S · Sale | Common Stock | 3494.0 | 80.35 |
| 2026-07-09 | Smith Mary L. | M · Exercise / conversion | Common Stock | 10000.0 | 42.95 |
| 2026-07-09 | Smith Mary L. | M · Exercise / conversion | Common Stock | 5834.0 | 42.95 |
| 2026-07-09 | Smith Mary L. | S · Sale | Common Stock | 5834.0 | 90.0 |
| 2026-07-09 | Smith Mary L. | S · Sale | Common Stock | 10000.0 | 90.0 |
| 2026-07-09 | Smith Mary L. | M · Exercise / conversion | Stock Option (Right to Buy) | 5834.0 | 0.0 |
| 2026-07-09 | Smith Mary L. | M · Exercise / conversion | Stock Option (Right to Buy) | 10000.0 | 0.0 |
| 2026-07-09 | Almstead Neil Gregory | S · Sale | Common Stock | 2464.0 | 90.25 |
| 2026-07-09 | Almstead Neil Gregory | M · Exercise / conversion | Common Stock | 2464.0 | 46.54 |
| 2026-07-09 | Almstead Neil Gregory | M · Exercise / conversion | Stock Option (Right to Buy) | 2464.0 | 0.0 |
| 2026-07-07 | Almstead Neil Gregory | S · Sale | Common Stock | 9288.0 | 89.44 |
| 2026-07-07 | Almstead Neil Gregory | S · Sale | Common Stock | 11369.0 | 89.03 |
| 2026-07-07 | Almstead Neil Gregory | S · Sale | Common Stock | 3956.0 | 87.17 |
| 2026-07-07 | Almstead Neil Gregory | M · Exercise / conversion | Common Stock | 24613.0 | 39.42 |
| 2026-07-07 | Almstead Neil Gregory | M · Exercise / conversion | Stock Option (Right to Buy) | 24613.0 | 0.0 |
| 2026-07-06 | Boulding Mark Elliott | S · Sale | Common Stock | 833.0 | 84.41 |
| 2026-07-06 | Boulding Mark Elliott | S · Sale | Common Stock | 313.0 | 83.1 |
| 2026-07-06 | Boulding Mark Elliott | M · Exercise / conversion | Common Stock | 2266.0 | 39.42 |
| 2026-07-06 | Boulding Mark Elliott | S · Sale | Common Stock | 745.0 | 86.38 |
| 2026-07-06 | Boulding Mark Elliott | S · Sale | Common Stock | 519.0 | 85.84 |
| 2026-07-06 | Boulding Mark Elliott | S · Sale | Common Stock | 1036.0 | 84.41 |
| 2026-07-06 | Boulding Mark Elliott | S · Sale | Common Stock | 387.0 | 83.1 |
| 2026-07-06 | Boulding Mark Elliott | M · Exercise / conversion | Common Stock | 2813.0 | 46.54 |
| 2026-07-06 | Boulding Mark Elliott | S · Sale | Common Stock | 601.0 | 86.38 |
| 2026-07-06 | Boulding Mark Elliott | S · Sale | Common Stock | 645.0 | 85.84 |
Identity & relationships
SEC issuer · 0001070081PTC THERAPEUTICS, INC.
- Legal Entity Identifier
- 549300UJLWOIWFDGB318
- GLEIF legal name
- PTC THERAPEUTICS, INC.
- Entity / LEI registration status
- ACTIVE / ISSUED
- Reference data updated
- 2026-07-15T04:30:13Z
Search names and former names
View Wikidata identity and references ↗
- PTC Therapeutics · alias · wikidata
- PTC THERAPEUTICS INC · former SEC name · 2004-01-02 to 2005-10-12
Revenue in constant purchasing power
| Year ended | Reported USD revenue | CPI-adjusted USD revenue |
|---|---|---|
| 2024-12-31 | $806.78M | $866.56M |
| 2023-12-31 | $937.82M | $1.04B |
| 2022-12-31 | $698.80M | $804.41M |
| 2021-12-31 | $538.59M | $669.61M |
| 2020-12-31 | $380.77M | $495.71M |
| 2019-12-31 | $306.98M | $404.56M |
| 2018-12-31 | $264.73M | $355.21M |
| 2017-12-31 | $194.39M | $267.20M |